Evidence map›Paper›PMID 39064975›Full record

ArticleMolecules (Basel, Switzerland)2024

The Effect of Technological Conditions on ABE Fermentation and Butanol Production of Rye Straw and the Composition of Volatile Compounds.

Wojciech Dziemianowicz, Katarzyna Kotarska, Anna Świerczyńska

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wojciech DziemianowiczDepartment of Distillery Technology and Renewable Energy, Prof. Wacław Dąbrowski Institute of Agriculture and Food Biotechnology-State Research Institute, Powstańców Wielkopolskich 17, 85-090 Bydgoszcz, Poland.
Katarzyna KotarskaDepartment of Distillery Technology and Renewable Energy, Prof. Wacław Dąbrowski Institute of Agriculture and Food Biotechnology-State Research Institute, Powstańców Wielkopolskich 17, 85-090 Bydgoszcz, Poland.
Anna ŚwierczyńskaDepartment of Distillery Technology and Renewable Energy, Prof. Wacław Dąbrowski Institute of Agriculture and Food Biotechnology-State Research Institute, Powstańców Wielkopolskich 17, 85-090 Bydgoszcz, Poland.

Funding

National Science Center 2018/31/N/ST8/03830
6 · The paper itself

Abstract

The objective of this study was to evaluate the effect of pretreatment and different technological conditions on the course of ABE fermentation of rye straw (RS) and the composition of volatile compounds in the distillates obtained. The highest concentration of ABE and butanol was obtained from the fermentation of pretreated rye straw by alkaline hydrolysis followed by detoxification and enzymatic hydrolysis. After 72 h of fermentation, the maximum butanol concentration, productivity, and yield from RS were 16.11 g/L, 0.224 g/L/h, and 0.402 g/g, respectively. Three different methods to produce butanol were tested: the two-step process (SHF), the simultaneous process (SSF), and simultaneous saccharification with ABE fermentation (consolidation SHF/SSF). The SHF/SSF process observed that ABE concentration (21.28 g/L) was higher than in the SSF (20.03 g/L) and lower compared with the SHF (22.21 g/L). The effect of the detoxification process and various ABE fermentation technologies on the composition of volatile compounds formed during fermentation and distillation were analyzed.

Indexed as

ButanolsFermentationSecaleVolatile Organic CompoundsDistillationHydrolysisButanolsVolatile Organic CompoundsABE fermentationbutanolenzymatic hydrolysislignocellulosic biomass

Identifiers

PMID39064975
PMCPMC11280078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.